The store will not work correctly when cookies are disabled.
6,8-Dichloro-9H-beta-carboline
ID: ALA78464
PubChem CID: 11075446
Max Phase: Preclinical
Molecular Formula: C11H6Cl2N2
Molecular Weight: 237.09
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1cc(Cl)c2[nH]c3cnccc3c2c1
Standard InChI: InChI=1S/C11H6Cl2N2/c12-6-3-8-7-1-2-14-5-10(7)15-11(8)9(13)4-6/h1-5,15H
Standard InChI Key: FMHUTFHLSOWTSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 17 0 0 0 0 0 0 0 0999 V2000
2.9417 -1.0500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2792 -0.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5375 0.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6125 -0.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3542 0.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4792 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9250 -0.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9792 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1792 0.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9667 -0.1292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2292 -1.5250 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.4167 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6292 1.2625 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.9125 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7125 0.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 1 1 0
5 4 2 0
6 2 1 0
7 6 2 0
8 3 1 0
9 7 1 0
10 12 2 0
11 6 1 0
12 4 1 0
13 9 1 0
14 5 1 0
15 10 1 0
5 3 1 0
15 14 2 0
8 9 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 237.09 | Molecular Weight (Monoisotopic): 235.9908 | AlogP: 4.02 | #Rotatable Bonds: ┄ |
Polar Surface Area: 28.68 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.06 | CX Basic pKa: 5.44 | CX LogP: 3.08 | CX LogD: 3.08 |
Aromatic Rings: 3 | Heavy Atoms: 15 | QED Weighted: 0.63 | Np Likeness Score: -0.64 |
References
1. Castro AC, Dang LC, Soucy F, Grenier L, Mazdiyasni H, Hottelet M, Parent L, Pien C, Palombella V, Adams J.. (2003) Novel IKK inhibitors: beta-carbolines., 13 (14): [PMID:12824047] [10.1016/s0960-894x(03)00408-6] |
2. Ikeda R, Kimura T, Tsutsumi T, Tamura S, Sakai N, Konakahara T.. (2012) Structure-activity relationship in the antitumor activity of 6-, 8- or 6,8-substituted 3-benzylamino-β-carboline derivatives., 22 (10): [PMID:22520257] [10.1016/j.bmcl.2012.03.077] |